Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesDaily pharmacologic prophylaxis of episodic migraine
Techniques in Regional Anesthesia and Pain Management, 06/25/09
Bamford CC et al. - Treatment should always begin with low doses and be gradually increased to optimal dosing, which then should be maintained for 2 to 3 months to evaluate effectiveness. Medications with the best evidence for efficacy in the prevention of migraine are amitriptyline, propranolol, timolol, valproate, and topiramate. Although all migraine preventive medications are nonspecific and have multiple potential mechanisms for their effects, they often share a tendency to reduce central neuronal hyperexcitability by inhibiting excitatory neurotransmitters, such as glutamate and norepinephrine, increasing inhibitory tone via GABA, reducing the likelihood of cortical spreading depression, or favorably altering channelopathies or mitochondriopathies thought to be intrinsic to migraine pathophysiology.
Related Articles
Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09
Relevance Score: 69%
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 69%
Urinary 6-Sulphatoxymelatonin Levels Are Depressed in Chronic Migraine and Several Comorbidities
Headache: The Journal of Head and Face Pain, 10/12/09
Relevance Score: 68%
Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting
The Journal of Headache and Pain, 11/10/09
Relevance Score: 67%
Expanding Access to Triptans: Assessment of Clinical Outcome
Headache: The Journal of Head and Face Pain, 10/12/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension
American Journal of Cardiovascular Drugs, 12/03/09
Beta-Blocker Therapy and Mortality of Patients with Chagas' Cardiomyopathy—a subanalysis of the REMADHE prospective trial
Circulation: Heart Failure, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor